All Peptide

Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino acid peptide fragment originally identified in the thymus. It has been studied extensively for its role in immune regulation, cellular signaling, and antiviral research contexts. As a thymic peptide, it is particularly noted for influencing T-cell activity, cytokine modulation, and immune resilience, which has made it a focus of both basic science and translational research.

Thymosin Alpha-1 (Tα1) is a naturally occurring 28-amino acid peptide fragment originally identified in the thymus. It has been studied extensively for its role in immune regulation, cellular signaling, and antiviral research contexts. As a thymic peptide, it is particularly noted for influencing T-cell activity, cytokine modulation, and immune resilience, which has made it a focus of both basic science and translational research.

Thymalin is a polypeptide complex originally isolated from the thymus and studied since the 1970s for its roles in immunomodulation, cellular regeneration, and aging-related research. It contains short peptide fragments (typically <10 amino acids) that regulate processes such as immune balance, hematopoiesis, and cellular differentiation. Due to these functions, Thymalin has remained a subject of extensive interest in both basic immunology and peptide science.

Tirzepatide is a dual-incretin peptide that functions as both a glucose-dependent insulinotropic polypeptide (GIP) and a glucagon-like peptide-1 (GLP-1) receptor agonist. It was designed to explore new approaches in metabolic research, including glucose regulation, appetite modulation, and weight management. By combining the effects of two incretin pathways in a single molecule, Tirzepatide represents a next-generation investigational co-agonist in peptide science.

Tirzepatide is a dual-incretin peptide that functions as both a glucose-dependent insulinotropic polypeptide (GIP) and a glucagon-like peptide-1 (GLP-1) receptor agonist. It was designed to explore new approaches in metabolic research, including glucose regulation, appetite modulation, and weight management. By combining the effects of two incretin pathways in a single molecule, Tirzepatide represents a next-generation investigational co-agonist in peptide science.

Tirzepatide is a dual-incretin peptide that functions as both a glucose-dependent insulinotropic polypeptide (GIP) and a glucagon-like peptide-1 (GLP-1) receptor agonist. It was designed to explore new approaches in metabolic research, including glucose regulation, appetite modulation, and weight management. By combining the effects of two incretin pathways in a single molecule, Tirzepatide represents a next-generation investigational co-agonist in peptide science.

Tirzepatide is a dual-incretin peptide that functions as both a glucose-dependent insulinotropic polypeptide (GIP) and a glucagon-like peptide-1 (GLP-1) receptor agonist. It was designed to explore new approaches in metabolic research, including glucose regulation, appetite modulation, and weight management. By combining the effects of two incretin pathways in a single molecule, Tirzepatide represents a next-generation investigational co-agonist in peptide science.

Tirzepatide is a dual-incretin peptide that functions as both a glucose-dependent insulinotropic polypeptide (GIP) and a glucagon-like peptide-1 (GLP-1) receptor agonist. It was designed to explore new approaches in metabolic research, including glucose regulation, appetite modulation, and weight management. By combining the effects of two incretin pathways in a single molecule, Tirzepatide represents a next-generation investigational co-agonist in peptide science.

Tirzepatide is a dual-incretin peptide that functions as both a glucose-dependent insulinotropic polypeptide (GIP) and a glucagon-like peptide-1 (GLP-1) receptor agonist. It was designed to explore new approaches in metabolic research, including glucose regulation, appetite modulation, and weight management. By combining the effects of two incretin pathways in a single molecule, Tirzepatide represents a next-generation investigational co-agonist in peptide science.

Vilon is a synthetic dipeptide (Lys–Glu) originally derived from thymic research, known for its roles in immune regulation, tissue repair, and epigenetic modulation. Despite its minimal structure, it has demonstrated broad biological activity in laboratory studies, including effects on immune balance, gene activation, and longevity support.